Genmab A/S (GNMSF)
376.00
-20.97
(-5.28%)
USD |
OTCM |
Oct 06, 16:00
Genmab Market Cap : 22.45B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 22.45B |
| October 05, 2026 | 23.70B |
| October 02, 2026 | 21.19B |
| October 01, 2026 | 21.19B |
| September 30, 2026 | 21.19B |
| September 29, 2026 | 21.19B |
| September 28, 2026 | 21.19B |
| September 25, 2026 | 21.07B |
| September 24, 2026 | 20.70B |
| September 23, 2026 | 20.22B |
| September 22, 2026 | 20.90B |
| September 21, 2026 | 20.48B |
| September 18, 2026 | 20.48B |
| September 17, 2026 | 20.48B |
| September 16, 2026 | 20.36B |
| September 15, 2026 | 20.24B |
| September 14, 2026 | 19.66B |
| September 11, 2026 | 19.66B |
| September 10, 2026 | 19.66B |
| September 09, 2026 | 19.66B |
| September 08, 2026 | 19.66B |
| September 04, 2026 | 19.66B |
| September 03, 2026 | 20.18B |
| September 02, 2026 | 20.18B |
| September 01, 2026 | 20.18B |
| Date | Value |
|---|---|
| August 31, 2026 | 20.18B |
| August 28, 2026 | 20.18B |
| August 27, 2026 | 20.18B |
| August 26, 2026 | 20.12B |
| August 25, 2026 | 20.12B |
| August 24, 2026 | 19.56B |
| August 21, 2026 | 20.12B |
| August 20, 2026 | 20.00B |
| August 19, 2026 | 19.10B |
| August 18, 2026 | 19.10B |
| August 17, 2026 | 19.10B |
| August 14, 2026 | 18.54B |
| August 13, 2026 | 18.54B |
| August 12, 2026 | 18.60B |
| August 11, 2026 | 18.60B |
| August 10, 2026 | 18.60B |
| August 07, 2026 | 18.60B |
| August 06, 2026 | 17.61B |
| August 05, 2026 | 17.31B |
| August 04, 2026 | 17.30B |
| August 03, 2026 | 17.31B |
| July 31, 2026 | 17.75B |
| July 30, 2026 | 17.75B |
| July 29, 2026 | 17.75B |
| July 28, 2026 | 17.75B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 14.85B |
| Zealand Pharma A/S | 2.661B |
| Bavarian Nordic A/S | 2.528B |
| Evaxion AS | 26.36M |
| ACADIA Pharmaceuticals, Inc. | 3.398B |
Market Cap Related Metrics
| PE Ratio | 29.70 |
| PS Ratio | 5.800 |
| Price to Book Value | 3.768 |
| Price to Free Cash Flow | 26.90 |
| Price | 376.00 |
| Earnings Yield | 3.37% |
| Operating PE Ratio | 17.96 |
| Normalized PE Ratio | 24.35 |